{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:55:54Z","timestamp":1789757754135,"version":"4.0.1"},"reference-count":56,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T00:00:00Z","timestamp":1729123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH130354"],"award-info":[{"award-number":["R01MH130354"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["T32MH019960"],"award-info":[{"award-number":["T32MH019960"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R25DK123008"],"award-info":[{"award-number":["R25DK123008"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["R01MH115502"],"award-info":[{"award-number":["R01MH115502"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["P50MH115843"],"award-info":[{"award-number":["P50MH115843"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"name":"COMPASS pathways"},{"name":"LB Pharmaceuticals, Inc."},{"DOI":"10.13039\/100017478","name":"Usona Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017478","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Alkermes, Inc"},{"name":"Joe and Sandy Samberg Foundation"},{"DOI":"10.13039\/100016230","name":"Steven and Alexandra Cohen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016230","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,25]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Psychedelics (e.g., 3,4-Methylenedioxymethamphetamine [MDMA], lysergic acid diethylamide [LSD], psilocybin) are molecules that have the potential to produce rapid therapeutic effects when paired with psychotherapy. Randomized clinical trials of psychedelic-assisted psychotherapy (PAT) have shown promising results for post-traumatic stress disorder (PTSD), depression, and substance use disorders. The U.S. Food and Drug Administration has acknowledged the promise of PAT, signaling potential approval of psilocybin-assisted therapy for depression by 2026. Given this timeline, implementation scientists must engage with PAT researchers, policymakers, and practitioners to think critically about bringing these promising new treatments into routine practice settings while maintaining quality and safety. This commentary aims to initiate a dialogue between implementation scientists and PAT researchers and practitioners on addressing these questions with a lens toward equity. Specifically, we discuss how the field of implementation science can support PAT stakeholders to accelerate the translational process from research into practice, focusing specifically on safety-net settings (i.e., Federally Qualified Health Centers and Veterans Affairs health systems) that serve historically marginalized populations. We use the Reach, Effectiveness, Adoption, Implementation, and Maintenance (RE-AIM) Framework to illustrate five critical areas where implementation science can help move PAT from research into real-world practice. For each RE-AIM dimension, we highlight ways the field of implementation science can contribute tools (e.g., implementation strategies), methodologies (e.g., pragmatic hybrid implementation-effectiveness trials), and approaches (community-based participatory research) for establishing the safety, effectiveness, and accessibility of PAT for historically underserved communities.<\/jats:p>","DOI":"10.1093\/tbm\/ibae053","type":"journal-article","created":{"date-parts":[[2024,10,18]],"date-time":"2024-10-18T02:38:29Z","timestamp":1729219109000},"page":"744-752","source":"Crossref","is-referenced-by-count":8,"title":["Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science"],"prefix":"10.1093","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3892-989X","authenticated-orcid":false,"given":"Danielle R","family":"Adams","sequence":"first","affiliation":[{"name":"School of Social Work, College of Health Sciences, University of Missouri-Columbia , Columbia, MO 65211 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Allen","sequence":"additional","affiliation":[{"name":"School of Social Work ,","place":["Colombia"]},{"name":"University , New York City, NY 10027 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5823-6129","authenticated-orcid":false,"given":"Ginger E","family":"Nicol","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, Washington University School of Medicine in St. Louis , MO 63110 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1872-4141","authenticated-orcid":false,"given":"Leopoldo J","family":"Cabassa","sequence":"additional","affiliation":[{"name":"Brown School of Social Work, Washington University in St. Louis , MO 63105 ,","place":["USA"]},{"name":"Center for Mental Health Services Research, Washington University in St. Louis , MO 63105 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,10,17]]},"reference":[{"key":"2024112515374508300_CIT0001","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s10615-019-00743-x","article-title":"Social work and psychedelic-assisted therapies: practice considerations for breakthrough treatments","volume":"49","author":"Hutchison","year":"2021","journal-title":"Clin Soc Work J"},{"key":"2024112515374508300_CIT0002","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.euroneuro.2023.05.008","article-title":"Psychedelics in the treatment of eating disorders: rationale and potential mechanisms","volume":"75","author":"Calder","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"2024112515374508300_CIT0003","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.jad.2022.09.168","article-title":"Psychedelic therapy for depressive symptoms: a systematic review and meta-analysis","volume":"322","author":"Ko","year":"2023","journal-title":"J Affect Disord"},{"key":"2024112515374508300_CIT0004","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1080\/02791072.2020.1769878","article-title":"A meta-analysis of placebo-controlled trials of psychedelic-assisted therapy","volume":"52","author":"Luoma","year":"2020","journal-title":"J Psychoactive Drugs"},{"key":"2024112515374508300_CIT0005","doi-asserted-by":"publisher","first-page":"1134454","DOI":"10.3389\/fpsyt.2023.1134454","article-title":"Therapeutic effect of psilocybin in addiction: a systematic review","volume":"14","author":"van der Meer","year":"2023","journal-title":"Front Psychiatry"},{"key":"2024112515374508300_CIT0006","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1038\/s41591-023-02455-9","article-title":"Psilocybin therapy for females with anorexia nervosa: a phase 1, open-label feasibility study","volume":"29","author":"Peck","year":"2023","journal-title":"Nat Med"},{"key":"2024112515374508300_CIT0007","author":"Mind Medicine (MindMed) Inc","year":"2024"},{"key":"2024112515374508300_CIT0008","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/d41586-024-02857-w","article-title":"FDA rejects ecstasy as a therapy: what\u2019s next for psychedelics","volume":"633","author":"Reardon","year":"2024","journal-title":"Nature"},{"key":"2024112515374508300_CIT0009","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.euroneuro.2023.02.002","article-title":"Premise, promise and challenges of MDMA assisted therapy for PTSD","volume":"70","author":"Madero","year":"2023","journal-title":"Eur Neuropsychopharmacol"},{"key":"2024112515374508300_CIT0010","doi-asserted-by":"publisher","first-page":"112467","DOI":"10.1016\/j.psychres.2019.06.042","article-title":"Getting a clinical innovation into practice: an introduction to implementation strategies","volume":"283","author":"Kirchner","year":"2020","journal-title":"Psychiatry Res"},{"key":"2024112515374508300_CIT0011","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1093\/acprof:oso\/9780195398489.001.0001","volume-title":"Translation and Implementation of Evidence-Based Practice.","author":"Palinkas","year":"2011"},{"key":"2024112515374508300_CIT0012","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1007\/s10488-008-0197-4","article-title":"Implementation research in mental health services: an emerging science with conceptual, methodological, and training challenges","volume":"36","author":"Proctor","year":"2009","journal-title":"Adm Policy Ment Health"},{"key":"2024112515374508300_CIT0013","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1080\/17512433.2023.2295997","article-title":"Set and setting predict psychopathology, wellbeing and meaningfulness of psychedelic experiences: a correlational study","volume":"17","author":"Borkel","year":"2024","journal-title":"Expert Rev Clin Pharmacol"},{"key":"2024112515374508300_CIT0014","doi-asserted-by":"publisher","first-page":"205032451668332","DOI":"10.1177\/2050324516683325","article-title":"Constructing drug effects: a history of set and setting","volume":"3","author":"Hartogsohn","year":"2017","journal-title":"Drug Sci Policy Law"},{"key":"2024112515374508300_CIT0015","doi-asserted-by":"publisher","first-page":"887255","DOI":"10.3389\/fpsyg.2022.887255","article-title":"Psychedelic-assisted psychotherapy\u2014a systematic review of associated psychological interventions","volume":"13","author":"Cavarra","year":"2022","journal-title":"Front Psychol"},{"key":"2024112515374508300_CIT0016","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1468-2850.2009.01187.x","article-title":"Training therapists in evidence-based practice: a critical review of studies from a systems-contextual perspective","volume":"17","author":"Beidas","year":"2010","journal-title":"Clin Psychol (New York)"},{"key":"2024112515374508300_CIT0017","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1017\/S0033291710000401","article-title":"Race\/ethnic differences in exposure to traumatic events, development of post-traumatic stress disorder, and treatment-seeking for post-traumatic stress disorder in the United States","volume":"41","author":"Roberts","year":"2011","journal-title":"Psychol Med"},{"key":"2024112515374508300_CIT0018","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s11414-018-9586-y","article-title":"Disparities in the treatment of substance use disorders: does where you live matter","volume":"45","author":"Acevedo","year":"2018","journal-title":"J Behav Health Serv Res"},{"key":"2024112515374508300_CIT0019","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2147\/ndt.s128584","article-title":"Racial and ethnic differences in depression: current perspectives","volume":"15","author":"Bailey","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"2024112515374508300_CIT0020","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.2105\/ajph.89.9.1322","article-title":"Evaluating the public health impact of health promotion interventions: the RE-AIM framework","volume":"89","author":"Glasgow","year":"1999","journal-title":"Am J Public Health"},{"key":"2024112515374508300_CIT0021","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1007\/s13142-013-0201-8","article-title":"Use of RE-AIM to address health inequities: application in a low-income community health center-based weight loss and hypertension self-management program","volume":"3","author":"Glasgow","year":"2013","journal-title":"Transl Behav Med"},{"key":"2024112515374508300_CIT0022","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1186\/s12888-018-1824-6","article-title":"Inclusion of people of color in psychedelic-assisted psychotherapy: a review of the literature","volume":"18","author":"Michaels","year":"2018","journal-title":"BMC Psychiatry"},{"key":"2024112515374508300_CIT0023","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1038\/s41591-023-02565-4","article-title":"MDMA-assisted therapy for moderate to severe PTSD: a randomized, placebo-controlled phase 3 trial","volume":"29","author":"Mitchell","year":"2023","journal-title":"Nat Med"},{"key":"2024112515374508300_CIT0024","author":"Multidisciplinary Association for Psychedelic Studies (MAPS)"},{"key":"2024112515374508300_CIT0025","author":"Multidisciplinary Association for Psychedelic Studies (MAPS)","year":"2022"},{"key":"2024112515374508300_CIT0026","article-title":"Mapping the margins: intersectionality, identity politics, and violence against women of color","volume-title":"The Public Nature of Private Violence.","author":"Crenshaw","year":"1994"},{"key":"2024112515374508300_CIT0027","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s12913-020-4975-3","article-title":"Reframing implementation science to address inequities in healthcare delivery","volume":"20","author":"Baumann","year":"2020","journal-title":"BMC Health Serv Res"},{"key":"2024112515374508300_CIT0028","author":"National Institute of Health","journal-title":"RFA-MD-13-001: Limited Competition: NIMHD Community-Based Participatory Research (CBPR) Initiative in Reducing and Eliminating Health Disparities: Dissemination Phase (R24)."},{"key":"2024112515374508300_CIT0029","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/S0140-6736(22)01470-2","article-title":"The Lancet Commission on ending stigma and discrimination in mental health","volume":"400","author":"Thornicroft","year":"2022","journal-title":"Lancet"},{"key":"2024112515374508300_CIT0030","doi-asserted-by":"publisher","first-page":"103429","DOI":"10.1016\/j.drugpo.2021.103429","article-title":"Enhancing equity-oriented care in psychedelic medicine: utilizing the EQUIP framework","volume":"98","author":"Rea","year":"2021","journal-title":"Int J Drug Policy"},{"key":"2024112515374508300_CIT0031","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-publhealth-031816-044215","article-title":"An overview of research and evaluation designs for dissemination and implementation","volume":"38","author":"Brown","year":"2017","journal-title":"Annu Rev Public Health"},{"key":"2024112515374508300_CIT0032","author":"Office of the Commissioner","year":"2018"},{"key":"2024112515374508300_CIT0033","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1001\/jamapsychiatry.2020.3285","article-title":"Effects of psilocybin-assisted therapy on major depressive disorder: a randomized clinical trial","volume":"78","author":"Davis","year":"2021","journal-title":"JAMA Psychiatry"},{"key":"2024112515374508300_CIT0034","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N Engl J Med"},{"key":"2024112515374508300_CIT0035","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","article-title":"Effectiveness-implementation hybrid designs","volume":"50","author":"Curran","year":"2012","journal-title":"Med Care"},{"key":"2024112515374508300_CIT0036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S2045796020000633","article-title":"Comorbidity within mental disorders: a comprehensive analysis based on 145 990 survey respondents from 27 countries","volume":"29","author":"McGrath","year":"2020","journal-title":"Epidemiol Psychiatr Sci"},{"key":"2024112515374508300_CIT0037","author":"Gukasyan","year":"2024"},{"key":"2024112515374508300_CIT0038","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1748-5908-4-50","article-title":"Fostering implementation of health services research findings into practice: a consolidated framework for advancing implementation science","volume":"4","author":"Damschroder","year":"2009","journal-title":"Implement Sci"},{"key":"2024112515374508300_CIT0039","author":"Government Executive","year":"2024","journal-title":"VA to Begin Researching Psychedelics as Treatment Option for Veterans"},{"key":"2024112515374508300_CIT0040","volume-title":"A Manual for MDMA-Assisted Psychotherapy in the Treatment of Posttraumatic Stress Disorder.","author":"Multidisciplinary Association for Psychedelic Studies","year":"2016"},{"key":"2024112515374508300_CIT0041","first-page":"1","article-title":"Audit and feedback: effects on professional practice and healthcare outcomes","volume":"6","author":"Ivers","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2024112515374508300_CIT0042","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/oso\/9780190937300.001.0001","volume-title":"Addressing Health Inequities in People with Serious Mental Illness: A Call to Action.","author":"Cabassa","year":"2023"},{"key":"2024112515374508300_CIT0043","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/1077558711430690","article-title":"A compilation of strategies for implementing clinical innovations in health and mental health","volume":"69","author":"Powell","year":"2012","journal-title":"Med Care Res Rev"},{"key":"2024112515374508300_CIT0044","first-page":"709","volume-title":"Planning Health Promotion Programs: An Intervention Mapping Approach.","author":"Eldredge","year":"2016"},{"key":"2024112515374508300_CIT0045","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1177\/1524839905278810","article-title":"Using intervention mapping to develop a breast and cervical cancer screening program for Hispanic farmworkers: Cultivando La Salud","volume":"6","author":"Fern\u00e1ndez","year":"2005","journal-title":"Health Promot Pract"},{"key":"2024112515374508300_CIT0046","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1186\/s12889-018-5329-5","article-title":"Use of intervention mapping to adapt a health behavior change intervention for endometrial cancer survivors: the shape-up following cancer treatment program","volume":"18","author":"Koutoukidis","year":"2018","journal-title":"BMC Public Health"},{"key":"2024112515374508300_CIT0047","author":"MACPAC","year":"2021","journal-title":"Access to Mental Health Services for Adults Covered by Medicaid."},{"key":"2024112515374508300_CIT0048","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1377\/hlthaff.2022.00805","article-title":"Medicaid reimbursement for psychiatric services: comparisons across states and with Medicare","volume":"42","author":"Zhu","year":"2023","journal-title":"Health Aff (Millwood)"},{"key":"2024112515374508300_CIT0049","doi-asserted-by":"publisher","first-page":"1025726","DOI":"10.3389\/fpsyt.2022.1025726","article-title":"The economics of psychedelic-assisted therapies: a research agenda","volume":"13","author":"Marseille","year":"2022","journal-title":"Front Psychiatry"},{"key":"2024112515374508300_CIT0050","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/jamapsychiatry.2022.4101","article-title":"Psychedelic drug legislative reform and legalization in the US","volume":"80","author":"Siegel","year":"2023","journal-title":"JAMA Psychiatry"},{"key":"2024112515374508300_CIT0051","author":"Los Angeles Times","year":"2023","journal-title":"MDMA-Assisted Therapy Could Soon Be Approved by the FDA. Will Insurance Cover It?"},{"key":"2024112515374508300_CIT0052","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12954-021-00489-1","article-title":"Ethical and legal issues in psychedelic harm reduction and integration therapy","volume":"18","author":"Pilecki","year":"2021","journal-title":"Harm Reduct J"},{"key":"2024112515374508300_CIT0053","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41386-022-01361-x","article-title":"Sustained effects of single doses of classical psychedelics in humans","volume":"48","author":"Knudsen","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"2024112515374508300_CIT0054","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1748-5908-8-65","article-title":"Development of a framework and coding system for modifications and adaptations of evidence-based interventions","volume":"8","author":"Stirman","year":"2013","journal-title":"Implement Sci"},{"key":"2024112515374508300_CIT0055","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/1748-5908-8-117","article-title":"The dynamic sustainability framework: addressing the paradox of sustainment amid ongoing change","volume":"8","author":"Chambers","year":"2013","journal-title":"Implement Sci"},{"key":"2024112515374508300_CIT0056","author":"United States Drug Enforcement Administration","journal-title":"Drug Scheduling."}],"container-title":["Translational Behavioral Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/tbm\/advance-article-pdf\/doi\/10.1093\/tbm\/ibae053\/60810691\/ibae053.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/tbm\/advance-article-pdf\/doi\/10.1093\/tbm\/ibae053\/60810691\/ibae053.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T15:38:07Z","timestamp":1732549087000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/tbm\/article\/14\/12\/744\/7825843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,17]]},"references-count":56,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,10,17]]},"published-print":{"date-parts":[[2024,11,25]]}},"URL":"https:\/\/doi.org\/10.1093\/tbm\/ibae053","relation":{},"ISSN":["1869-6716","1613-9860"],"issn-type":[{"value":"1869-6716","type":"print"},{"value":"1613-9860","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,12]]},"published":{"date-parts":[[2024,10,17]]}}}